Wells Fargo maintains Xenon Pharmaceuticals overweight
Benzinga reports that Wells Fargo is maintaining Xenon Pharmaceuticals at an overweight rating.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.